Table 3.
Prevalence in use of psychotropic drugs according to nursing home admission
| A2 | A3 | |
|---|---|---|
| NHA/no NHA | NHA/no NHA | |
| (N = 89/510) | (N = 114/339) | |
| Psychotropic drug use | ||
| Antipsychotics (AP) | 11.2 / 3.5** | 18.4 / 2.7*** |
| Traditional AP | 7.9 / 3.1* | 12.3 / 2.7*** |
| Atypical AP | 4.5 / 0.4** | 7.0 / 0 |
| Antidepressants | 33.7 / 17.8** | 43.0 / 15.3*** |
| Anxiolytics | 20.2 / 10.4* | 21.1 / 8.6** |
| Sedatives | 25.8 / 20.6 | 32.5 / 19.5** |
| Anti-dementia drugs | 23.6 / 7.6*** | 20.2 / 3.2*** |
| Any PTD | 67.4 / 41.6*** | 73.7 / 37.2*** |
A2: Assessment 2, 18 months after baseline
A3: Assessment 3, 36 months after baseline
NHA Nursing home admission, no NHA Living at home, PTD Psychotropic drugs
* p < 0.05; ** p < 0.01; *** p < 0.001; p-values were calculated by generalized linear mixed model adjusting for municipality level if present